PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Largest ever study of childhood ALL shows improving survival

21,626-person study shows 90.4 percent survival

2012-03-13
(Press-News.org) A 21,626-person study published today in the Journal of Clinical Oncology found that the five-year survival rate for children and adolescents with acute lymphoblastic leukemia (ALL), the most common childhood cancer, improved from 83.7 percent in those diagnosed during the years 1990-1994, to 90.4 percent for those diagnosed in the years 2000-2005.

"The improved survival is due to using existing drugs better, not because of the introduction of new drugs. We're indebted to all the families who choose to join these clinical trials, allowing us to optimize these combinations," says Stephen Hunger, MD, investigator at the University of Colorado Cancer Center, professor of pediatrics at the University of Colorado School of Medicine, and director of the Center for Cancer and Blood Disorders at Children's Hospital Colorado, the study's lead author.

Data included all patients aged 0-22 years who received treatment on a Children's Oncology Group clinical trial, between 1990 and 2005. These patients represented an estimated 55.8 percent of ALL cases diagnosed in the United States during this period.

"I wonder how much more we could improve therapy for, say, breast cancer if half of all women with that disease were enrolled in clinical trials," Hunger says.

Additional findings include significant improvements in survival for African American patients with ALL, which narrowed the racial survival gap. Also, the only group in which survival didn't increase during this period was infants less than one year old, whose decrease in death from leukemia relapse was offset by an increase in treatment-related mortality.

"In early 1960s this disease was incurable," Hunger says. "Then in the late 1960s, the cure rate was 10 percent. Now almost 90 percent of children and adolescents diagnosed with ALL will be cured. Still, a 90-percent survival rate is little consolation to the 10 percent of families whose child doesn't survive. There's still more work to be done."

According to Hunger, this work is likely to take two forms: predicting high-risk ALL patients early enough to affect treatment decisions, and the development of new, targeted therapies.

For example, adding the drug imatinib (gleevec) to the treatment of children with ALL that have a specific alteration known as the Philadelphia chromosome nearly doubled survival. In the next ten years, Hunger hopes similarly targeted drugs will chip away at the remaining 10 percent ALL mortality.

"I actually met a person last year who was one of the first kids cured at Children's Hospital, in the late 1960s – he's my age and works at the airport," Hunger says. "He talked about watching most of the children he met with ALL die. Now almost all will live."

For Hunger and other members of his group, "almost all" is not enough.

INFORMATION:

About the University of Colorado Cancer Center:

Headquartered on the University of Colorado Anschutz Medical Campus, the CU Cancer Center is a consortium of three state universities and six institutions. Together, our more than 440 members are working to ease the cancer burden through cancer care, research, education and prevention and control.

Additionally, nearly all researchers who participate in cancer-related basic, translational, clinical, population and behavioral research in Colorado are CU Cancer Center members. This statewide inclusiveness of cancer researchers and academic institutions provides great scientific breadth and depth strengthening the CU Cancer Center's research.

We are committed to transforming cancer research and practice in the state of Colorado by creating an integrated interdisciplinary nexus of clinicians and scientists across our statewide consortium that can leverage, synergize, marshal and focus resources and expertise to discover new ways to prevent and treat cancer.

About The Children's Oncology Group:

The Children's Oncology Group (childrensoncologygroup.org), a National Cancer Institute supported clinical trials group, is the world's largest organization devoted exclusively to childhood and adolescent cancer research. The Children's Oncology Group (COG) unites more than 7,500 experts in childhood cancer at more than 200 leading children's hospitals, universities, and cancer centers across North America, Australia, New Zealand, and Europe in the fight against childhood cancer. COG research has turned children's cancer from a virtually incurable disease 50 years ago into one with an overall cure rate approaching 80 percent today. Research conducted by the COG is also supported through the generosity of individuals, corporations and private foundations working with The Children's Oncology Group Foundation (TheCOGFoundation.org), which enables philanthropic resources to go directly to COG's worldwide team of researchers committed to turning new discoveries into better treatments.

END



ELSE PRESS RELEASES FROM THIS DATE:

Extensive taste loss in mammals

2012-03-13
PHILADELPHIA (March 12, 2012) – Scientists from the Monell Center report that seven of 12 related mammalian species have lost the sense of sweet taste. As each of the sweet-blind species eats only meat, the findings demonstrate that a liking for sweets is frequently lost during the evolution of diet specialization. Previous research from the Monell team had revealed the remarkable finding that both domestic and wild cats are unable to taste sweet compounds due to defects in a gene that controls structure of the sweet taste receptor. Cats are obligate carnivores, meaning ...

Medically prescribed heroin more effective, less costly than current methadone treatment

2012-03-13
Medically prescribed heroin is more cost-effective than methadone for treating long-term street heroin users, according to a new study by researchers at Providence Health Care and the University of British Columbia. The study, published today in the Canadian Medical Association Journal (CMAJ), attributed most of the economic benefits to the fact that recipients of medically prescribed heroin (diacetylmorphine) stayed in treatment longer and spent less time in relapse than those receiving methadone. Both results are associated with reduced criminal activity and lower health ...

Major study stops bladder cancer from metastasizing to lungs

2012-03-13
The diagnosis of localized bladder cancer carries an 80 percent five-year survival rate, but once the cancer spreads, the survival rate at even three years is only 20 percent. A major study published today in the Journal of Clinical Investigation not only shows how bladder cancer metastasizes to the lungs but pinpoints a method for stopping this spread. Specifically, the study shows that versican, a protein involved in cancer cell migration, is a driver of lung metastasis and that high levels of versican are associated with poor prognosis in bladder cancer patients. The ...

JCI early table of contents for March 12, 2012

2012-03-13
EDITOR'S PICK Restoring what's lost: uncovering how liver tissue regenerates The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal. Laurie DeLeve and her colleagues at the University of Southern California in Los Angeles wanted to better understand which cells are specifically responsible for driving liver regeneration. A specialized cell type, known as liver sinusoidal endothelial cells, has generally been thought to promote regeneration of liver tissue. However, the DeLeve team suspected ...

Craftmark Countertops Points Out that Granite is Still a Bargain

2012-03-13
Granite countertops in Atlanta have a lot of competition these days with the popularity of concrete, recycled glass, soapstone, quartz, and a host of other surfaces gaining ground in the Atlanta countertops market. However, Craftmark Countertops in Atlanta points out that the look and longevity of Atlanta granite countertops is comparable to the other surfaces and often a fraction of the cost. With its rise in popularity over the last decade, granite is no longer a surface of exclusivity, and so some higher end homes are being built with other more expensive surfaces. ...

Restoring what's lost: Uncovering how liver tissue regenerates

2012-03-13
The liver is unique among mammalian organs in its ability to regenerate after significant tissue damage or even partial surgical removal. Laurie DeLeve and her colleagues at the University of Southern California in Los Angeles wanted to better understand which cells are specifically responsible for driving liver regeneration. A specialized cell type, known as liver sinusoidal endothelial cells, has generally been thought to promote regeneration of liver tissue. However, the DeLeve team suspected that stem cells and progenitor cells, which have the capacity to differentiate ...

Sugar-sweetened drinks linked to increased risk of heart disease in men

2012-03-13
Men who drank a 12-ounce sugar-sweetened beverage a day had a 20 percent higher risk of heart disease compared to men who didn't drink any sugar-sweetened drinks, according to research published in Circulation, an American Heart Association journal. "This study adds to the growing evidence that sugary beverages are detrimental to cardiovascular health," said Frank B. Hu, M.D., Ph.D., study lead author and professor of nutrition and epidemiology in the Harvard School of Public Health in Boston, Mass. "Certainly, it provides strong justification for reducing sugary beverage ...

Red meat consumption linked to increased risk of total, cardiovascular, and cancer mortality

2012-03-13
Boston, MA -- A new study from Harvard School of Public Health (HSPH) researchers has found that red meat consumption is associated with an increased risk of total, cardiovascular, and cancer mortality. The results also showed that substituting other healthy protein sources, such as fish, poultry, nuts, and legumes, was associated with a lower risk of mortality. The study will be published online in Archives of Internal Medicine on March 12, 2012. "Our study adds more evidence to the health risks of eating high amounts of red meat, which has been associated with type ...

More red meat consumption appears to be associated with increased risk of death

2012-03-13
CHICAGO – Eating more red meat appears to be associated with an increased risk of all-cause mortality and death from cardiovascular disease and cancer, but substituting other foods including fish and poultry for red meat is associated with a lower mortality risk, according to a study published Online First by Archives of Internal Medicine, one of the JAMA/Archives journals. Meat is a major source of protein and fat in many diets and previous studies suggest that eating meat is associated with increased risk for diabetes, cardiovascular disease (CVD) and certain cancers, ...

Prescribing opioids for pain after short-stay surgery appears associated with long-term use

2012-03-13
CHICAGO – Prescribing opioids for pain to older patients within seven days of short-stay surgery appears to be associated with long-term analgesic use compared to those patients who did not receive prescriptions for analgesics after surgery, according to a study published in the March 12 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Patients are frequently prescribed analgesics after ambulatory or short-stay surgery in anticipation of postoperative pain and the most common analgesics prescribed to outpatients are opioids (such as codeine and ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Largest ever study of childhood ALL shows improving survival
21,626-person study shows 90.4 percent survival